Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - JP
$ 12.92
-0.996 %
$ 41 B
Market Cap
22.28
P/E
TAK - COST OF REVENUE
Cost of Revenue TAK - Takeda Pharmaceutical Company Limited
1.43
LAST VALUE
13.72%
2 YEAR CAGR
16.76%
5 YEAR CAGR
11.31%
10 YEAR CAGR